Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Ear Block in Middle Ear Surgery
NCT03569046Completed
- Start
- Jul 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in tympanic membrane perforation (2 arms). Primary endpoint: Mean Arterial Blood Pressure. Started Jul 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
tympanic membrane perforation
Beyond the preview
Go deeper on NCT03569046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03569046.